NewAge Inc (fka NBEVQ) (NBEVQ)

[NewJerichoMan]

$nBEV Peer Comparison

If, emphasis on if, 2017 revenues are $92M, with $10.5M EBITDA, this is how $nBEV charts in relation to its peers.

Yesterday's presentation noted 29M shares. I'm at 32M and change. I'm adding the ESOP shares and something else (I forget). So I'm a little ahead on the share count (~5%) but its nominal.

Looking at the screeners, which list TTM figures per GAAP, we look over-valued. But when considering our future prospects and our growth, we appear vastly under-valued.

No doubt this company is winning with the retailers. The latest example is Aspen Pure Probiotics and CVS Caremark Pharmacies. We just don't know if we're gonna win with the customers. I have a warm, fuzzy feeling about it but I'm biased as he!! on this topic.